Publications by authors named "Archontoula Antonoglou"
Article Synopsis
- Post-COVID-19 syndrome affects millions, and while rehabilitation is important, studies show mixed results due to variations in participant characteristics and factors like age and disease severity that are not well understood.
- This non-randomized case-control study involved participants with post-COVID-19 symptoms, comparing those who attended an 8-week supervised rehabilitation program to those who did not, with measurements taken at the start and after the program.
- Results indicated that participants in rehabilitation showed significant improvements in various health metrics, including walking distance, physical performance, quality of life, and cognitive function, further highlighting the potential benefits of rehabilitation for post-COVID-19 recovery.
Background: Patients who were infected with COVID-19 may experience Long COVID syndrome. We examined the effectiveness of physiotherapy on dyspnea, muscle strength, and functional status in Long COVID syndrome.
Methods: The exercise group underwent an 8-week supervised physiotherapeutic program consisting of interval aerobic exercise and strengthening exercises, each lasting 30 min.
Article Synopsis
- - The study examined serum levels of GFAP, s100b, and total Tau in long-COVID patients to investigate links to symptoms, cognitive decline, mental health issues, and quality of life.
- - It included 65 long-COVID patients and 20 controls, finding that GFAP levels were higher in patients but didn’t correlate with long-COVID symptoms; other biomarkers like s100b and total Tau showed no significant difference.
- - The research highlighted high rates of cognitive decline (65.9%), depression (32.2%), anxiety (47.5%), and PTSD (44.1%) among long-COVID patients, with most participants scoring below normal on quality of life assessments.
Since the beginning of the pandemic, both COVID-19-associated coagulopathy biomarkers and a plethora of endothelial biomarkers have been proposed and tested as prognostic tools of severity and mortality prediction. As the pandemic is gradually being controlled, attention is now focusing on the long-term sequelae of COVID-19. In the present study, we investigated the role of endothelial activation/dysfunction in long COVID syndrome.
View Article and Find Full Text PDFVaccination remains the best strategy against coronavirus disease 2019 (COVID-19) in terms of prevention. The efficacy and safety of COVID-19 vaccines is supported by well-designed clinical trials that recruited many participants. It is well-known that vaccination is associated with local side effects related to the injection site, and mild, systemic side effects.
View Article and Find Full Text PDFLong COVID-19 syndrome refers to persisting symptoms (>12 weeks) after the initial coronavirus infection and is estimated to affect 3% to 12% of people diagnosed with the disease globally. Aim: We conducted a collaborative study with the Long COVID patient organization in Greece, in order to estimate the characteristics, symptoms, and challenges these patients confront. Methods: Data were collected from 208 patients using unstructured qualitative free-text entries in an anonymized online questionnaire.
View Article and Find Full Text PDF